A research study in Peru to test an intervention called DIALOG+ designed to improve care for people living in the community with severe mental illness
This study isn't currently recruiting.
In Peru
Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
This study isn't currently recruiting.
In PeruThis study isn't currently recruiting.
In United KingdomThis study isn't currently recruiting.
In United KingdomThis study isn't currently recruiting.
In Czech RepublicThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaOpen-Label Single Dose Pilot Study to Assess Safety, Tolerability and Pharmacokinetics of Risperidone Extended Release Capsules in Patients with Schizophrenia, Schizoaffective Disorder or Bipolar 1 Disorder
This study was withdrawn before enrollment.
In MelbourneTaurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study.
This study has finished and is no longer accepting participants.
In BelmontThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaA Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyA Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive Episode (GH001-BD-202)
Original registry wording; source language not specified.
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.